Report Detail

Medical Devices & Consumables Global Human Leukocyte Antigen (HLA) Testing Market Size, Status and Forecast 2020-2026

  • RnM4268576
  • |
  • 16 December, 2020
  • |
  • Global
  • |
  • 94 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Human Leukocyte Antigen (HLA) Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Molecular Assay Technologies
    • 1.3.3 Non-molecular Assay Technologies
  • 1.4 Market by Application
    • 1.4.1 Global Human Leukocyte Antigen (HLA) Testing Market Share by Application: 2020 VS 2026
    • 1.4.2 Hospital
    • 1.4.3 Research Institute
    • 1.4.4 Other
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Human Leukocyte Antigen (HLA) Testing Market Perspective (2015-2026)
  • 2.2 Human Leukocyte Antigen (HLA) Testing Growth Trends by Regions
    • 2.2.1 Human Leukocyte Antigen (HLA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Human Leukocyte Antigen (HLA) Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Human Leukocyte Antigen (HLA) Testing Industry Dynamic
    • 2.3.1 Human Leukocyte Antigen (HLA) Testing Market Trends
    • 2.3.2 Human Leukocyte Antigen (HLA) Testing Market Drivers
    • 2.3.3 Human Leukocyte Antigen (HLA) Testing Market Challenges
    • 2.3.4 Human Leukocyte Antigen (HLA) Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Human Leukocyte Antigen (HLA) Testing Players by Market Size
    • 3.1.1 Global Top Human Leukocyte Antigen (HLA) Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Human Leukocyte Antigen (HLA) Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Human Leukocyte Antigen (HLA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Human Leukocyte Antigen (HLA) Testing Revenue
  • 3.4 Global Human Leukocyte Antigen (HLA) Testing Market Concentration Ratio
    • 3.4.1 Global Human Leukocyte Antigen (HLA) Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Human Leukocyte Antigen (HLA) Testing Revenue in 2019
  • 3.5 Key Players Human Leukocyte Antigen (HLA) Testing Area Served
  • 3.6 Key Players Human Leukocyte Antigen (HLA) Testing Product Solution and Service
  • 3.7 Date of Enter into Human Leukocyte Antigen (HLA) Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Human Leukocyte Antigen (HLA) Testing Breakdown Data by Type

  • 4.1 Global Human Leukocyte Antigen (HLA) Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Type (2021-2026)

5 Human Leukocyte Antigen (HLA) Testing Breakdown Data by Application

  • 5.1 Global Human Leukocyte Antigen (HLA) Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Human Leukocyte Antigen (HLA) Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Human Leukocyte Antigen (HLA) Testing Market Size (2015-2026)
  • 6.2 North America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2015-2020)
  • 6.3 North America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2015-2020)
  • 6.4 North America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Human Leukocyte Antigen (HLA) Testing Market Size (2015-2026)
  • 7.2 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Type (2015-2020)
  • 7.3 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Application (2015-2020)
  • 7.4 Europe Human Leukocyte Antigen (HLA) Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size (2015-2026)
  • 8.2 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Human Leukocyte Antigen (HLA) Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Human Leukocyte Antigen (HLA) Testing Market Size (2015-2026)
  • 9.2 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Type (2015-2020)
  • 9.3 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Application (2015-2020)
  • 9.4 Latin America Human Leukocyte Antigen (HLA) Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size (2015-2026)
  • 10.2 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Human Leukocyte Antigen (HLA) Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Details
    • 11.1.2 Thermo Fisher Scientific Business Overview
    • 11.1.3 Thermo Fisher Scientific Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.1.4 Thermo Fisher Scientific Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020))
    • 11.1.5 Thermo Fisher Scientific Recent Development
  • 11.2 F. Hoffman-La Roche
    • 11.2.1 F. Hoffman-La Roche Company Details
    • 11.2.2 F. Hoffman-La Roche Business Overview
    • 11.2.3 F. Hoffman-La Roche Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.2.4 F. Hoffman-La Roche Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.2.5 F. Hoffman-La Roche Recent Development
  • 11.3 Bio-Rad Laboratories
    • 11.3.1 Bio-Rad Laboratories Company Details
    • 11.3.2 Bio-Rad Laboratories Business Overview
    • 11.3.3 Bio-Rad Laboratories Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.3.4 Bio-Rad Laboratories Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.3.5 Bio-Rad Laboratories Recent Development
  • 11.4 QIAGEN N.V.
    • 11.4.1 QIAGEN N.V. Company Details
    • 11.4.2 QIAGEN N.V. Business Overview
    • 11.4.3 QIAGEN N.V. Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.4.4 QIAGEN N.V. Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.4.5 QIAGEN N.V. Recent Development
  • 11.5 Illumina
    • 11.5.1 Illumina Company Details
    • 11.5.2 Illumina Business Overview
    • 11.5.3 Illumina Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.5.4 Illumina Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.5.5 Illumina Recent Development
  • 11.6 Immucor
    • 11.6.1 Immucor Company Details
    • 11.6.2 Immucor Business Overview
    • 11.6.3 Immucor Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.6.4 Immucor Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.6.5 Immucor Recent Development
  • 11.7 CareDx
    • 11.7.1 CareDx Company Details
    • 11.7.2 CareDx Business Overview
    • 11.7.3 CareDx Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.7.4 CareDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.7.5 CareDx Recent Development
  • 11.8 Becton Dickinson
    • 11.8.1 Becton Dickinson Company Details
    • 11.8.2 Becton Dickinson Business Overview
    • 11.8.3 Becton Dickinson Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.8.4 Becton Dickinson Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.8.5 Becton Dickinson Recent Development
  • 11.9 Hologic
    • 11.9.1 Hologic Company Details
    • 11.9.2 Hologic Business Overview
    • 11.9.3 Hologic Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.9.4 Hologic Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.9.5 Hologic Recent Development
  • 11.10 GenDx
    • 11.10.1 GenDx Company Details
    • 11.10.2 GenDx Business Overview
    • 11.10.3 GenDx Human Leukocyte Antigen (HLA) Testing Introduction
    • 11.10.4 GenDx Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 11.10.5 GenDx Recent Development
  • 11.11 Biofortuna
    • 10.11.1 Biofortuna Company Details
    • 10.11.2 Biofortuna Business Overview
    • 10.11.3 Biofortuna Human Leukocyte Antigen (HLA) Testing Introduction
    • 10.11.4 Biofortuna Revenue in Human Leukocyte Antigen (HLA) Testing Business (2015-2020)
    • 10.11.5 Biofortuna Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Human Leukocyte Antigen (HLA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Leukocyte Antigen (HLA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Molecular Assay Technologies
    Non-molecular Assay Technologies

    Market segment by Application, split into
    Hospital
    Research Institute
    Other

    Based on regional and country-level analysis, the Human Leukocyte Antigen (HLA) Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Human Leukocyte Antigen (HLA) Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Thermo Fisher Scientific
    F. Hoffman-La Roche
    Bio-Rad Laboratories
    QIAGEN N.V.
    Illumina
    Immucor
    CareDx
    Becton Dickinson
    Hologic
    GenDx


    Summary:
    Get latest Market Research Reports on Human Leukocyte Antigen (HLA) Testing. Industry analysis & Market Report on Human Leukocyte Antigen (HLA) Testing is a syndicated market report, published as Global Human Leukocyte Antigen (HLA) Testing Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Human Leukocyte Antigen (HLA) Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,848.76
    4,273.13
    5,697.51
    3,206.77
    4,810.15
    6,413.53
    404,862.90
    607,294.35
    809,725.80
    284,485.50
    426,728.25
    568,971.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report